Correlation Between Quoin Pharmaceuticals and LMF Acquisition
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Quoin Pharmaceuticals and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and LMF Acquisition.
Diversification Opportunities for Quoin Pharmaceuticals and LMF Acquisition
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Quoin and LMF is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and LMF Acquisition go up and down completely randomly.
Pair Corralation between Quoin Pharmaceuticals and LMF Acquisition
Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the LMF Acquisition. In addition to that, Quoin Pharmaceuticals is 1.53 times more volatile than LMF Acquisition Opportunities. It trades about -0.14 of its total potential returns per unit of risk. LMF Acquisition Opportunities is currently generating about -0.12 per unit of volatility. If you would invest 282.00 in LMF Acquisition Opportunities on November 2, 2024 and sell it today you would lose (109.00) from holding LMF Acquisition Opportunities or give up 38.65% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Quoin Pharmaceuticals Ltd vs. LMF Acquisition Opportunities
Performance |
Timeline |
Quoin Pharmaceuticals |
LMF Acquisition Oppo |
Quoin Pharmaceuticals and LMF Acquisition Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Quoin Pharmaceuticals and LMF Acquisition
The main advantage of trading using opposite Quoin Pharmaceuticals and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Allarity Therapeutics | Quoin Pharmaceuticals vs. Biodexa Pharmaceticals |
LMF Acquisition vs. ZyVersa Therapeutics | LMF Acquisition vs. Sonnet Biotherapeutics Holdings | LMF Acquisition vs. Revelation Biosciences | LMF Acquisition vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |